Adial pharmaceuticals to host a virtual key opinion leader webinar to discuss the unmet need in alcohol use disorder

Pre-registration for the linkedin live event will begin on thursday, september 28th industry experts to discuss the need for non-abstinence-based therapies in alcohol use disorder (aud) charlottesville, va., sept. 28, 2023 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that on october 4, 2023, at 2:15 p.m.
ADIL Ratings Summary
ADIL Quant Ranking